These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 2160009)

  • 21. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress-hyporesponsive period.
    Chautard T; Boudouresque F; Guillaume V; Oliver C
    Neuroendocrinology; 1993 Jan; 57(1):70-8. PubMed ID: 8097578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of corticosterone secretion is modified by PFOS exposure at different levels of the hypothalamic-pituitary-adrenal axis in adult male rats.
    Pereiro N; Moyano R; Blanco A; Lafuente A
    Toxicol Lett; 2014 Oct; 230(2):252-62. PubMed ID: 24440345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.
    Bernardini R; Kamilaris TC; Calogero AE; Johnson EO; Gomez MT; Gold PW; Chrousos GP
    Endocrinology; 1990 Jun; 126(6):2876-81. PubMed ID: 2161738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.
    Gwosdow AR; Kumar MS; Bode HH
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E65-70. PubMed ID: 2154118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
    Garrido MM; Martin S; Ambrosio E; Fuentes JA; Manzanares J
    Neuroendocrinology; 1998 Aug; 68(2):116-22. PubMed ID: 9705578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis.
    Johnson EO; Kamilaris TC; Calogero AE; Gold PW; Chrousos GP
    Eur J Endocrinol; 2005 Jul; 153(1):177-85. PubMed ID: 15994759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis.
    Mikkelsen JD; Søderman A; Kiss A; Mirza N
    Eur J Pharmacol; 2005 Sep; 519(3):223-30. PubMed ID: 16125698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats.
    Widmaier EP; Rosen K; Abbott B
    Endocrinology; 1992 Nov; 131(5):2313-8. PubMed ID: 1330498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
    Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
    Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal and PAF-, interleukin 1-, ether stress-induced hypothalamic pituitary adrenal secretion of conscious rat: modulation by PAF antagonists.
    Rougeot C; Tiberghein C; Minary P; Dray F
    J Lipid Mediat; 1991; 4(1):45-59. PubMed ID: 1654152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat.
    Steiner MA; Sciarretta C; Brisbare-Roch C; Strasser DS; Studer R; Jenck F
    Psychoneuroendocrinology; 2013 Apr; 38(4):560-71. PubMed ID: 22917622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
    Belda X; Daviu N; Nadal R; Armario A
    Horm Behav; 2012 Sep; 62(4):515-24. PubMed ID: 22986335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence suggesting that ghrelin O-acyl transferase inhibitor acts at the hypothalamus to inhibit hypothalamo-pituitary-adrenocortical axis function in the rat.
    Rucinski M; Ziolkowska A; Szyszka M; Hochol A; Malendowicz LK
    Peptides; 2012 Jun; 35(2):149-59. PubMed ID: 22543218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.